{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T12:54:55Z","timestamp":1790254495065,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","medical.theclinics.com","clinicalkey.es","theclinics.com","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.mcna.2017.03.002","type":"journal-article","created":{"date-parts":[[2017,6,2]],"date-time":"2017-06-02T04:15:44Z","timestamp":1496376944000},"page":"673-688","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cardiovascular Risk Assessment"],"prefix":"10.1016","volume":"101","author":[{"given":"Mark J.","family":"Pletcher","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew E.","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.mcna.2017.03.002_bib1","doi-asserted-by":"crossref","first-page":"e38","DOI":"10.1161\/CIR.0000000000000350","article-title":"Heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"issue":"23","key":"10.1016\/j.mcna.2017.03.002_bib2","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1161\/CIRCULATIONAHA.107.738732","article-title":"Beyond established and novel risk factors: lifestyle risk factors for cardiovascular disease","volume":"117","author":"Mozaffarian","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mcna.2017.03.002_bib3","first-page":"957","article-title":"27th Bethesda Conference. Matching the intensity of risk factor management with the hazard for coronary disease events. September 14-15, 1995","volume":"27","year":"1996","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"19","key":"10.1016\/j.mcna.2017.03.002_bib4","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"issue":"25 Suppl 2","key":"10.1016\/j.mcna.2017.03.002_bib5","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mcna.2017.03.002_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gheart.2012.12.001","article-title":"Legacy of the Framingham Heart Study: rationale, design, initial findings, and implications","volume":"8","author":"Wong","year":"2013","journal-title":"Glob Heart"},{"issue":"18","key":"10.1016\/j.mcna.2017.03.002_bib7","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mcna.2017.03.002_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00043798-199602000-00010","article-title":"Comparison of multivariate predictive power of major risk factors for coronary heart diseases in different countries: results from eight nations of the Seven Countries Study, 25-year follow-up","volume":"3","author":"Menotti","year":"1996","journal-title":"J\u00a0Cardiovasc Risk"},{"key":"10.1016\/j.mcna.2017.03.002_bib9","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1001\/jama.286.2.180","article-title":"Validation of the Framingham coronary heart disease prediction scores","volume":"286","author":"D'Agostino","year":"2001","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.mcna.2017.03.002_bib10","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.291.21.2591","article-title":"Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study","volume":"291","author":"Liu","year":"2004","journal-title":"JAMA"},{"issue":"21","key":"10.1016\/j.mcna.2017.03.002_bib11","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1161\/CIRCULATIONAHA.105.607499","article-title":"Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults","volume":"114","author":"Wu","year":"2006","journal-title":"Circulation"},{"issue":"11","key":"10.1016\/j.mcna.2017.03.002_bib12","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S0195-668X(03)00114-3","article-title":"Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project","volume":"24","author":"Conroy","year":"2003","journal-title":"Eur Heart J"},{"issue":"7659","key":"10.1016\/j.mcna.2017.03.002_bib13","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ"},{"issue":"1245","key":"10.1016\/j.mcna.2017.03.002_bib14","first-page":"U2313","article-title":"Web-based assessment of cardiovascular disease risk in routine primary care practice in New Zealand: the first 18,000 patients (PREDICT CVD-1)","volume":"119","author":"Bannink","year":"2006","journal-title":"N\u00a0Z Med J"},{"issue":"19","key":"10.1016\/j.mcna.2017.03.002_bib15","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1001\/jama.2016.15450","article-title":"Statin use for the primary prevention of cardiovascular disease in adults: US Preventive Services Task Force recommendation statement","volume":"316","author":"Bibbins-Domingo","year":"2016","journal-title":"JAMA"},{"issue":"25 Suppl 2","key":"10.1016\/j.mcna.2017.03.002_bib16","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.mcna.2017.03.002_bib17","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M16-0577","article-title":"Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement","volume":"164","author":"Bibbins-Domingo","year":"2016","journal-title":"Ann Intern Med"},{"issue":"9907","key":"10.1016\/j.mcna.2017.03.002_bib18","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(13)62388-0","article-title":"Statins: new American guidelines for prevention of cardiovascular disease","volume":"382","author":"Ridker","year":"2013","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mcna.2017.03.002_bib19","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1161\/CIRCULATIONAHA.113.007648","article-title":"Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA\/ACC risk equation","volume":"129","author":"Muntner","year":"2014","journal-title":"Circulation"},{"issue":"14","key":"10.1016\/j.mcna.2017.03.002_bib20","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jama.2014.2630","article-title":"Validation of the atherosclerotic cardiovascular disease pooled cohort risk equations","volume":"311","author":"Muntner","year":"2014","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.mcna.2017.03.002_bib21","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.1016\/j.jacc.2015.09.089","article-title":"Primary prevention with statins: ACC\/AHA risk-based approach versus trial-based approaches to guide statin therapy","volume":"66","author":"Mortensen","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"11","key":"10.1016\/j.mcna.2017.03.002_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/M16-1739","article-title":"Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update","volume":"165","author":"Cook","year":"2016","journal-title":"Ann Intern Med"},{"issue":"15","key":"10.1016\/j.mcna.2017.03.002_bib23","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1056\/NEJMoa1315665","article-title":"Application of new cholesterol guidelines to a population-based sample","volume":"370","author":"Pencina","year":"2014","journal-title":"N\u00a0Engl J Med"},{"issue":"7","key":"10.1016\/j.mcna.2017.03.002_bib24","doi-asserted-by":"crossref","first-page":"496","DOI":"10.7326\/0003-4819-151-7-200910060-00010","article-title":"Emerging risk factors for coronary heart disease: a summary of systematic reviews conducted for the U.S. Preventive Services Task Force","volume":"151","author":"Helfand","year":"2009","journal-title":"Ann Intern Med"},{"issue":"25","key":"10.1016\/j.mcna.2017.03.002_bib25","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1056\/NEJMoa055373","article-title":"Multiple biomarkers for the prediction of first major cardiovascular events and death","volume":"355","author":"Wang","year":"2006","journal-title":"N\u00a0Engl J Med"},{"issue":"8","key":"10.1016\/j.mcna.2017.03.002_bib26","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA"},{"issue":"29","key":"10.1016\/j.mcna.2017.03.002_bib27","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.mcna.2017.03.002_bib28","unstructured":"American College of Cardiology. ASCVD risk estimator. Available at: http:\/\/tools.acc.org\/ASCVD-Risk-Estimator\/. Accessed April 2, 2017."},{"key":"10.1016\/j.mcna.2017.03.002_bib29","unstructured":"Reynolds Risk Score. Available at: http:\/\/www.reynoldsriskscore.org\/. Accessed April 2, 2017."},{"key":"10.1016\/j.mcna.2017.03.002_bib30","unstructured":"MESA. MESA 10-year CHD risk with coronary artery calcification. Available at: https:\/\/www.mesa-nhlbi.org\/MESACHDRisk\/MesaRiskScore\/RiskScore.aspx. Accessed April 2, 2017."},{"issue":"6","key":"10.1016\/j.mcna.2017.03.002_bib31","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCULATIONAHA.111.035725","article-title":"Integrating information from novel risk factors with calculated risks: the critical impact of risk factor prevalence","volume":"124","author":"Kooter","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.mcna.2017.03.002_bib32","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/CIRCULATIONAHA.113.002598","article-title":"Interpretation of the coronary artery calcium score in combination with conventional cardiovascular risk factors: the Multi-ethnic Study of Atherosclerosis (MESA)","volume":"128","author":"Pletcher","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.mcna.2017.03.002_bib33","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1741-7015-2-31","article-title":"What does my patient's coronary artery calcium score mean? Combining information from the coronary artery calcium score with information from conventional risk factors to estimate coronary heart disease risk","volume":"2","author":"Pletcher","year":"2004","journal-title":"BMC Med"},{"issue":"5","key":"10.1016\/j.mcna.2017.03.002_bib34","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1161\/CIRCOUTCOMES.115.001639","article-title":"Interpreting hemoglobin A1C in combination with conventional risk factors for prediction of cardiovascular risk","volume":"8","author":"Jarmul","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"12","key":"10.1016\/j.mcna.2017.03.002_bib35","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women","volume":"342","author":"Ridker","year":"2000","journal-title":"N\u00a0Engl J Med"},{"issue":"5","key":"10.1016\/j.mcna.2017.03.002_bib36","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1161\/CIRCULATIONAHA.105.594929","article-title":"Receiver-operating characteristic analysis for evaluating diagnostic tests and predictive models","volume":"115","author":"Zou","year":"2007","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mcna.2017.03.002_bib37","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/sim.2929","article-title":"Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond","volume":"27","author":"Pencina","year":"2008","journal-title":"Stat Med"},{"issue":"1","key":"10.1016\/j.mcna.2017.03.002_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-145-1-200607040-00128","article-title":"The effect of including C-reactive protein in cardiovascular risk prediction models for women","volume":"145","author":"Cook","year":"2006","journal-title":"Ann Intern Med"},{"issue":"10","key":"10.1016\/j.mcna.2017.03.002_bib39","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1161\/CIRCULATIONAHA.110.943860","article-title":"Evaluating the clinical utility of a biomarker: a review of methods for estimating health impact","volume":"123","author":"Pletcher","year":"2011","journal-title":"Circulation"},{"issue":"17","key":"10.1016\/j.mcna.2017.03.002_bib40","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1161\/CIRCULATIONAHA.109.192278","article-title":"Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Hlatky","year":"2009","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mcna.2017.03.002_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCOUTCOMES.113.000799","article-title":"Using the coronary artery calcium score to guide statin therapy: a cost-effectiveness analysis","volume":"7","author":"Pletcher","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"4","key":"10.1016\/j.mcna.2017.03.002_bib42","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0735-1097(90)90282-T","article-title":"Quantification of coronary artery calcium using ultrafast computed tomography","volume":"15","author":"Agatston","year":"1990","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"13","key":"10.1016\/j.mcna.2017.03.002_bib43","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMoa072100","article-title":"Coronary calcium as a predictor of coronary events in four racial or ethnic groups","volume":"358","author":"Detrano","year":"2008","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.mcna.2017.03.002_bib44","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1001\/jama.2010.461","article-title":"Coronary artery calcium score and risk classification for coronary heart disease prediction","volume":"303","author":"Polonsky","year":"2010","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.mcna.2017.03.002_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.7326\/0003-4819-151-7-200910060-00009","article-title":"C-reactive protein as a risk factor for coronary heart disease: a systematic review and meta-analyses for the U.S. Preventive Services Task Force","volume":"151","author":"Buckley","year":"2009","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.mcna.2017.03.002_bib46","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1161\/CIRCOUTCOMES.108.831198","article-title":"C-reactive protein and reclassification of cardiovascular risk in the Framingham Heart Study","volume":"1","author":"Wilson","year":"2008","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"15","key":"10.1016\/j.mcna.2017.03.002_bib47","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1161\/CIRCULATIONAHA.110.947960","article-title":"Cost-effectiveness of using high-sensitivity C-reactive protein to identify intermediate- and low-cardiovascular-risk individuals for statin therapy","volume":"122","author":"Lee","year":"2010","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.mcna.2017.03.002_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/CIRCULATIONAHA.109.912568","article-title":"Assessing the role of circulating, genetic, and imaging biomarkers in cardiovascular risk prediction","volume":"123","author":"Wang","year":"2011","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.mcna.2017.03.002_bib49","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults","volume":"362","author":"Selvin","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"18","key":"10.1016\/j.mcna.2017.03.002_bib50","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/j.jacc.2011.12.062","article-title":"Genes and coronary artery disease: where are we?","volume":"60","author":"Roberts","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mcna.2017.03.002_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Deloukas","year":"2013","journal-title":"Nat Genet"},{"issue":"9984","key":"10.1016\/j.mcna.2017.03.002_bib52","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0140-6736(14)61730-X","article-title":"Genetic risk, coronary heart disease events, and the clinical benefit of statin therapy: an analysis of primary and secondary prevention trials","volume":"385","author":"Mega","year":"2015","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.mcna.2017.03.002_bib53","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1161\/CIRCGENETICS.116.001522","article-title":"Clinical utility of multi-marker genetic risk scores for prediction of incident coronary heart disease: a cohort study among over 51 thousand individuals of European ancestry","volume":"9","author":"Iribarren","year":"2016","journal-title":"Circ Cardiovasc Genet"},{"issue":"4","key":"10.1016\/j.mcna.2017.03.002_bib54","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jacl.2014.05.008","article-title":"Cascade screening based on genetic testing is cost-effective: evidence for the implementation of models of care for familial hypercholesterolemia","volume":"8","author":"Ademi","year":"2014","journal-title":"J\u00a0Clin Lipidol"},{"issue":"5","key":"10.1016\/j.mcna.2017.03.002_bib55","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s40258-013-0053-x","article-title":"Economic evaluation of Cardio inCode\u00ae, a clinical-genetic function for coronary heart disease risk assessment","volume":"11","author":"Ramirez de Arellano","year":"2013","journal-title":"Appl Health Econ Health Policy"},{"issue":"17","key":"10.1016\/j.mcna.2017.03.002_bib56","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1056\/NEJMoa1602777","article-title":"Child-parent familial hypercholesterolemia screening in primary care","volume":"375","author":"Wald","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2017.03.002_bib57","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1001\/jama.2016.6423","article-title":"Lipid screening in childhood and adolescence for detection of multifactorial dyslipidemia: evidence report and systematic review for the US preventive services task force","volume":"316","author":"Lozano","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.mcna.2017.03.002_bib58","unstructured":"Statin Choice: Decision Aid. Available at: https:\/\/statindecisionaid.mayoclinic.org\/. Accessed April 2, 2017."},{"key":"10.1016\/j.mcna.2017.03.002_bib59","unstructured":"Gluckman TJ. The ACC\/AHA ASCVD risk estimator app and the EHR FHIR integration project. Available at: https:\/\/www.himssconference.org\/sites\/himssconference\/files\/pdf\/IS22.pdf. Accessed April 2, 2017."},{"issue":"3","key":"10.1016\/j.mcna.2017.03.002_bib60","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s12265-016-9687-z","article-title":"Improvement in cardiovascular risk prediction with electronic health records","volume":"9","author":"Pike","year":"2016","journal-title":"J\u00a0Cardiovasc Transl Res"},{"issue":"5","key":"10.1016\/j.mcna.2017.03.002_bib61","doi-asserted-by":"crossref","first-page":"e0154288","DOI":"10.1371\/journal.pone.0154288","article-title":"Young adult exposure to cardiovascular risk factors and risk of events later in life: the Framingham Offspring Study","volume":"11","author":"Pletcher","year":"2016","journal-title":"PLoS One"},{"issue":"21","key":"10.1016\/j.mcna.2017.03.002_bib62","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1001\/jama.282.21.2012","article-title":"Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy: findings for 5 large cohorts of young adult and middle-aged men and women","volume":"282","author":"Stamler","year":"1999","journal-title":"JAMA"},{"issue":"4","key":"10.1016\/j.mcna.2017.03.002_bib63","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1056\/NEJMoa1012848","article-title":"Lifetime risks of cardiovascular disease","volume":"366","author":"Berry","year":"2012","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2017.03.002_bib64","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrcardio.2012.185","article-title":"Adding a life-course perspective to cardiovascular-risk communication","volume":"10","author":"Karmali","year":"2013","journal-title":"Nat Rev Cardiol"},{"issue":"8","key":"10.1016\/j.mcna.2017.03.002_bib65","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jacc.2010.05.018","article-title":"Statin prescribing in young adults: ready for prime time?","volume":"56","author":"Pletcher","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.mcna.2017.03.002_bib66","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jacc.2009.12.057","article-title":"Earlier intervention in the management of hypercholesterolemia: what are we waiting for?","volume":"56","author":"Steinberg","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.mcna.2017.03.002_bib67","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jacc.2015.08.857","article-title":"Next steps in primary prevention of coronary heart disease: rationale for and design of the ECAD trial","volume":"66","author":"Domanski","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"9841","key":"10.1016\/j.mcna.2017.03.002_bib68","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"issue":"16","key":"10.1016\/j.mcna.2017.03.002_bib69","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.115.018383","article-title":"Individualized statin benefit for determining statin eligibility in the primary prevention of cardiovascular disease","volume":"133","author":"Thanassoulis","year":"2016","journal-title":"Circulation"},{"issue":"26","key":"10.1016\/j.mcna.2017.03.002_bib70","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJM200106283442601","article-title":"Measurement of C-reactive protein for the targeting of statin therapy in the primary prevention of acute coronary events","volume":"344","author":"Ridker","year":"2001","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.mcna.2017.03.002_bib71","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"2","key":"10.1016\/j.mcna.2017.03.002_bib72","first-page":"2","article-title":"Population impact and efficiency of benefit-targeted vs. risk-targeted statin prescribing for primary prevention of cardiovascular disease","volume":"6","author":"Pletcher","year":"2017","journal-title":"J\u00a0Am Heart Assoc"},{"issue":"2","key":"10.1016\/j.mcna.2017.03.002_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7326\/0003-4819-136-2-200201150-00015","article-title":"Aspirin for the primary prevention of cardiovascular events: recommendation and rationale","volume":"136","year":"2002","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.mcna.2017.03.002_bib74","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1001\/jamacardio.2016.2861","article-title":"Assessing cardiovascular risk to guide hypertension diagnosis and treatment","volume":"1","author":"Navar","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"21","key":"10.1016\/j.mcna.2017.03.002_bib75","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1161\/CIRCULATIONAHA.113.002290","article-title":"Using benefit-based tailored treatment to improve the use of antihypertensive medications","volume":"128","author":"Sussman","year":"2013","journal-title":"Circulation"},{"issue":"22","key":"10.1016\/j.mcna.2017.03.002_bib76","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A\u00a0randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Group","year":"2015","journal-title":"N\u00a0Engl J Med"},{"issue":"21","key":"10.1016\/j.mcna.2017.03.002_bib77","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","article-title":"Blood-pressure lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Lonn","year":"2016","journal-title":"N\u00a0Engl J Med"},{"issue":"4","key":"10.1016\/j.mcna.2017.03.002_bib78","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/HYP.0000000000000003","article-title":"An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention","volume":"63","author":"Go","year":"2014","journal-title":"Hypertension"},{"issue":"25","key":"10.1016\/j.mcna.2017.03.002_bib79","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mcna.2017.03.002_bib80","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.mcna.2017.03.002_bib81","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1161\/CIRCULATIONAHA.108.814251","article-title":"C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men","volume":"118","author":"Ridker","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.mcna.2017.03.002_bib82","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.mcna.2017.03.002_bib83","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jacc.2014.06.1186","article-title":"A\u00a0systematic examination of the 2013 ACC\/AHA pooled cohort risk assessment tool for atherosclerotic cardiovascular disease","volume":"64","author":"Karmali","year":"2014","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.mcna.2017.03.002_bib84","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2015.08.035","volume":"66","author":"McClelland","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.mcna.2017.03.002_bib85","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1001\/jamacardio.2015.0300","article-title":"Development and validation of risk prediction models for cardiovascular events in black adults: the Jackson Heart Study cohort","volume":"1","author":"Fox","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"5","key":"10.1016\/j.mcna.2017.03.002_bib86","doi-asserted-by":"crossref","first-page":"342","DOI":"10.7326\/0003-4819-159-5-201309030-00008","article-title":"Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement","volume":"159","author":"Moyer","year":"2013","journal-title":"Ann Intern Med"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712517300251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712517300251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,25]],"date-time":"2019-09-25T11:58:54Z","timestamp":1569412734000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712517300251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":86,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S0025712517300251"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2017.03.002","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular Risk Assessment","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2017.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}